CAYLOR CALLAGHAN: Open Payments
NPI 1336717610 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,664 in 82 payments from 18 companies in 2025. Trend: 2023 $724 · 2024 $1,151 · 2025 $1,664
Food & beverage: $1,664
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $347 |
| Ardelyx, Inc. | 10 | $164 |
| ABBVIE INC. | 9 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $141 |
| GENZYME CORPORATION | 4 | $104 |
| PFIZER INC. | 4 | $83 |
| Aimmune Therapeutics, Inc. | 2 | $77 |
| Ipsen Biopharmaceuticals, Inc | 3 | $71 |
| Madrigal Pharmaceuticals | 3 | $65 |
Products named: TREMFYA, IBSRELA, XIFAXAN, DUPIXENT, LINZESS, ZENPEP, ENTYVIO, IQIRVO.
Industry payments across PA — which companies pay providers there.
